BRAF gene test kits

Result display time: 4 h

... is malignant neoplasm driven by various of tumorigenesis factors. Gene mutations caused by environment and heredity (including point mutation, deletion, insertion, copy number gain, gene fusion and so on) may lead to ...

1.Multiple myeloma diagnosis and treatment guidelines suggest that FISH detection sites include: IGH translocation, 17p- (P53 deletion), 13q14 deletion, 1q21 amplification. If FISH detects positive IGH translocation, then further testing for t(4;14), ...

... . To judge breast cancer prognosis: HER2 gene amplification patient prognosis difference, disease-free survival and total survival significantly shortened. 3. Breast cancer endocrine treatment Guide: HER2 gene amplification ...

... 1. ZNF217 gene was amplified in breast cancer, and its status was related to tumor invasion. 2. ZNF217 gene was also amplified in other tumors such as ovarian/colorectal/head and neck/pancreatic cancer, and was an important ...

... 1. In non-small cell lung cancer, inv (2) (P21; P23) forms a molecular subunit of the fusion gene EML4-ALK, which is the target of the targeted drug Crizotinib. 2. A new EML4-ALK evaluation item was added to the 2010 non-small cell lung ...

... 1.The gene amplification rate was higher in lung squamous cell carcinoma patients; 2.There was a significant difference in EGFR mutation rate between those without amplification and those without amplification. 3.The prognosis is worse. ...

... 1. It was divided into two reaction tests, one is detecting deletion of chromosome 3 and P16 genes, another is looking for abnormalities in chromosome 7 and 17; 2. Urine exfoliated cells were used for detection, and ...

... 1.AURKA gene plays an important role in maintaining cell balance. 2.AURKA gene amplification can occur in various tumors such as breast cancer/ovarian cancer/colorectal cancer/prostate cancer/cervical cancer/neuroblastoma. ...

1. The deletion of the entire chromosome 7 or the entire long arm 7q is a recurrent abnormality of MDS. It happens in approximately 5-10% AML(M4 and M6) ,in approximately 15% adult MDS, 40% child MDS and 50% treatment-related AML/MDS. Most of the deletion ...

... 1. 6Q21 will be amplified in MM and CLL. 2. 15Q22 is amplified in MM. ...

... occur in 50% B-cell NHL and many other types of lymphoma, which can translocate with more than 50 genes. 2.This probe is used to detect whether the IGH gene is broken and translocated. ...